Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paris Roach

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Pharmacokinetics|August 14, 2008
New insulin analogues and routes of delivery: pharmacodynamic and clinical considerationsParis Roach
BMJ (Clinical Research Ed.)|December 14, 2004
Better systems, not guidelines, for glucose monitoringParis Roach
Diabetes Forecast|April 26, 2018
Is type 2 diabetes reversible?Paris Roach
Vascular Health and Risk Management|February 24, 2007
A critical dialogue: communicating with type 2 diabetes patients about cardiovascular riskParis Roach, David Marrero
Diabetes Care|November 1, 2015
Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes After Treatment With EmpagliflozinParis Roach, Paul Skierczynski
Clinical Pharmacokinetics|October 31, 2002
Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixturesParis Roach, James R Woodworth
Medical Care|January 22, 2004
Good diabetes care: more than cheap medsRonald T Ackermann, Paris Roach, David G Marrero
Clinical Therapeutics|August 22, 2009
Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient settingNancy M Yoon, Melissa K Cavaghan, Rocco L Brunelle, et al.
Clinical Therapeutics|June 11, 2004
Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitusParis Roach, Shan Bai, Bernard Charbonnel, et al.
Communication & Medicine|June 15, 2013
Listening to patients' voices: linguistic indicators related to diabetes self-managementUlla Connor, Marta Anton, Elizabeth Goering, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Pharmacokinetics|August 14, 2008
New insulin analogues and routes of delivery: pharmacodynamic and clinical considerationsParis Roach
BMJ (Clinical Research Ed.)|December 14, 2004
Better systems, not guidelines, for glucose monitoringParis Roach
Diabetes Forecast|April 26, 2018
Is type 2 diabetes reversible?Paris Roach
Vascular Health and Risk Management|February 24, 2007
A critical dialogue: communicating with type 2 diabetes patients about cardiovascular riskParis Roach, David Marrero
Diabetes Care|November 1, 2015
Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes After Treatment With EmpagliflozinParis Roach, Paul Skierczynski
Clinical Pharmacokinetics|October 31, 2002
Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixturesParis Roach, James R Woodworth
Medical Care|January 22, 2004
Good diabetes care: more than cheap medsRonald T Ackermann, Paris Roach, David G Marrero
Clinical Therapeutics|August 22, 2009
Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient settingNancy M Yoon, Melissa K Cavaghan, Rocco L Brunelle, et al.
Clinical Therapeutics|June 11, 2004
Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitusParis Roach, Shan Bai, Bernard Charbonnel, et al.
Communication & Medicine|June 15, 2013
Listening to patients' voices: linguistic indicators related to diabetes self-managementUlla Connor, Marta Anton, Elizabeth Goering, et al.
Pageof 2